AGP Executive Report
Last update: 9 minutes agoBiotech: Henderson-based Zura Bio said its Phase 2 trial of tibulizumab for hidradenitis suppurativa missed its primary and key secondary endpoints, a setback for the company’s drug-development program. Gaming: Wynn Resorts’ third-quarter profit fell to $17.3 million as results weakened across all four operating segments. Nevada regulators also recommended five new sportsbook licenses, including for William Hill and Boomer’s. Housing: Southern Nevada home prices reached $475,000, but sales continued to slide as higher mortgage rates weighed on buyers. Local Business: Arts District businesses say construction is cutting foot traffic and sales, prompting calls for emergency relief. Mining: Metso secured a €9 million order for new dry-grinding technology at a Nevada operation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.